How does pain induce negative emotion? Role of the bed nucleus of the stria terminalis in pain-induced place aversion

Current Molecular Medicine

Volumn 15, Issue 2, 2015, Pages 184-190

  Minami, M ^a   Ide, S ^a  

^a HOKKAIDO UNIVERSITY   (Japan)

Author keywords

Bed nucleus of the stria terminalis; Depression; Dopamine; Emotion; Extended amygdala; Noradrenaline; Pain; Ventral tegmental area

Indexed keywords

CORTICOTROPIN RELEASING FACTOR; NEUROPEPTIDE Y; NORADRENALIN; 4 AMINOBUTYRIC ACID RECEPTOR;

ADRENERGIC TRANSMISSION; ANHEDONIA; ANTERIOR CINGULATE; ARTICLE; AVERSION; BASOLATERAL AMYGDALA; BED NUCLEUS; BEHAVIOR; CHRONIC PAIN; DEPRESSION; DOPAMINERGIC NERVE CELL; DOPAMINERGIC TRANSMISSION; ELECTROPHYSIOLOGY; EMOTION; GABAERGIC TRANSMISSION; GLUTAMATERGIC SYNAPSE; HUMAN; NERVE CELL EXCITABILITY; NOCICEPTIVE PAIN; PAIN; STRIA TERMINALIS; SYNAPTIC TRANSMISSION; ANIMAL; CINGULATE GYRUS; DISEASE MODEL; FRUSTRATION; METABOLISM; NOCICEPTION; PAIN MEASUREMENT; PATHOLOGY; PATHOPHYSIOLOGY; PSYCHOLOGY; RAT; SEPTUM NUCLEUS; VENTRAL TEGMENTUM;

ANIMALS; BASOLATERAL NUCLEAR COMPLEX; CORTICOTROPIN-RELEASING HORMONE; DISEASE MODELS, ANIMAL; DOPAMINERGIC NEURONS; FRUSTRATION; GABAERGIC NEURONS; GYRUS CINGULI; HUMANS; NOCICEPTION; NOREPINEPHRINE; PAIN; PAIN MEASUREMENT; RATS; SEPTAL NUCLEI; VENTRAL TEGMENTAL AREA;

EID: 84930936722     PISSN: 15665240     EISSN: 18755666     Source Type: Journal    
DOI: 10.2174/1566524015666150303002336     Document Type: Article

References (50)

1. Johansen JP, Fields HL, Manning BH. The affective component of pain in rodents: direct evidence for a contribution of the anterior cingulate cortex. Proc Natl Acad Sci U S A 2001; 98(14): 8077-82.
2. Johansen JP, Fields HL. Glutamatergic activation of anterior cingulate cortex produces an aversive teaching signal. Nat Neurosci 2004; 7(4): 398-403.
3. Lei LG, Sun S, Gao YJ, Zhao ZQ, Zhang YQ. NMDA receptors in the anterior cingulate cortex mediate painrelated aversion. Exp Neurol 2004; 189(2): 413-21.
4. Ren WH, Guo JD, Cao H, et al. Is endogenous D-serine in the rostral anterior cingulate cortex necessary for painrelated negative affect? J Neurochem 2006; 96(6): 1636-47.
5. Gallagher M, Chiba AA. The amygdala and emotion. Curr Opin Neurobiol 1996; 6(2): 221-7.
6. Bernard JF, Besson JM. The spino(trigemino)pontoamygdaloid pathway: electrophysiological evidence for an involvement in pain processes. J Neurophysiol 1990; 63(3): 473-90.
7. Neugebauer V, Li W. Processing of nociceptive mechanical and thermal information in central amygdala neurons with knee-joint input. J Neurophysiol 2002; 87(1): 103-12.
8. Nakagawa T, Katsuya A, Tanimoto S, et al. Differential patterns of c-fos mRNA expression in the amygdaloid nuclei induced by chemical somatic and visceral noxious stimuli in rats. Neurosci Lett 2003; 344(3): 197-200.
9. Tanimoto S, Nakagawa T, Yamauchi Y, Minami M, Satoh M. Differential contributions of the basolateral and central nuclei of the amygdala in the negative affective component of chemical somatic and visceral pains in rats. Eur J Neurosci 2003; 18(8): 2343-50.
10. Deyama S, Yamamoto J, Machida T, et al. Inhibition of glutamatergic transmission by morphine in the basolateral amygdaloid nucleus reduces pain-induced aversion. Neurosci Res 2007; 59(2): 199-204.
11. Cecchi M, Khoshbouei H, Javors M, Morilak DA. Modulatory effects of norepinephrine in the lateral bed nucleus of the stria terminalis on behavioral and neuroendocrine responses to acute stress. Neuroscience 2002; 112(1): 13-21.
12. Delfs JM, Zhu Y, Druhan JP, Aston-Jones G. Noradrenaline in the ventral forebrain is critical for opiate withdrawalinduced aversion. Nature 2000; 403(6768): 430-4.
13. Fendt M, Siegl S, Steiniger-Brach B. Noradrenaline transmission within the ventral bed nucleus of the stria terminalis is critical for fear behavior induced by trimethylthiazoline, a component of fox odor. J Neurosci 2005; 25(25): 5998-6004.
14. Nakagawa T, Yamamoto R, Fujio M, et al. Involvement of the bed nucleus of the stria terminalis activated by the central nucleus of the amygdala in the negative affective component of morphine withdrawal in rats. Neuroscience 2005; 134(1): 9-19.
15. Sahuque LL, Kullberg EF, McGeehan AJ, et al. Anxiogenic and aversive effects of corticotropin-releasing factor (CRF) in the bed nucleus of the stria terminalis in the rat: role of CRF receptor subtypes. Psychopharmacology (Berl) 2006; 186(1): 122-32.
16. Sullivan GM, Apergis J, Bush DE, Johnson LR, Hou M, Ledoux JE. Lesions in the bed nucleus of the stria terminalis disrupt corticosterone and freezing responses elicited by a contextual but not by a specific cue-conditioned fear stimulus. Neuroscience 2004; 128(1): 7-14.
17. Walker DL, Davis M. Double dissociation between the involvement of the bed nucleus of the stria terminalis and the central nucleus of the amygdala in startle increases produced by conditioned versus unconditioned fear. J Neurosci 1997; 17(23): 9375-83.
18. Braz JM, Nassar MA, Wood JN, Basbaum AI. Parallel "pain" pathways arise from subpopulations of primary afferent nociceptor. Neuron 2005; 47(6): 787-93.
19. Gauriau C, Bernard JF. Pain pathways and parabrachial circuits in the rat. Exp Physiol 2002; 87(2): 251-8.
20. Deyama S, Nakagawa T, Kaneko S, Uehara T, Minami M. Involvement of the bed nucleus of the stria terminalis in the negative affective component of visceral and somatic pain in rats. Behav Brain Res 2007; 176(2): 367-71.
21. Forray MI, Gysling K, Andres ME, Bustos G, Araneda S. Medullary noradrenergic neurons projecting to the bed nucleus of the stria terminalis express mRNA for the NMDANR1 receptor. Brain Res Bull 2000; 52(3): 163-9.
22. Woulfe JM, Flumerfelt BA, Hrycyshyn AW. Efferent connections of the A1 noradrenergic cell group: a DBH immunohistochemical and PHA-L anterograde tracing study. Exp Neurol 1990; 109(3): 308-22.
23. Deyama S, Katayama T, Kondoh N, et al. Role of enhanced noradrenergic transmission within the ventral bed nucleus of the stria terminalis in visceral pain-induced aversion in rats. Behav Brain Res 2009; 197(2): 279-83.
24. Deyama S, Katayama T, Ohno A, et al. Activation of the beta-adrenoceptor-protein kinase A signaling pathway within the ventral bed nucleus of the stria terminalis mediates the negative affective component of pain in rats. J Neurosci 2008; 28(31): 7728-36.
25. Morin SM, Ling N, Liu XJ, Kahl SD, Gehlert DR. Differential distribution of urocortin-and corticotropin-releasing factor-like immunoreactivities in the rat brain. Neuroscience 1999; 92(1): 281-91.
26. Sakanaka M, Shibasaki T, Lederis K. Distribution and efferent projections of corticotropin-releasing factor-like immunoreactivity in the rat amygdaloid complex. Brain Res 1986; 382(2): 213-38.
27. Van Pett K, Viau V, Bittencourt JC, et al. Distribution of mRNAs encoding CRF receptors in brain and pituitary of rat and mouse. J Comp Neurol 2000; 428(2): 191-212.
28. Lee Y, Davis M. Role of the hippocampus, the bed nucleus of the stria terminalis, and the amygdala in the excitatory effect of corticotropin-releasing hormone on the acoustic startle reflex. J Neurosci 1997; 17(16): 6434-46.
29. Ide S, Hara T, Ohno A, et al. Opposing roles of corticotropinreleasing factor and neuropeptide Y within the dorsolateral bed nucleus of the stria terminalis in the negative affective component of pain in rats. J Neurosci 2013; 33(14): 5881-94.
30. Walter A, Mai JK, Lanta L, Gorcs T. Differential distribution of immunohistochemical markers in the bed nucleus of the stria terminalis in the human brain. J Chem Neuroanat 1991; 4(4): 281-98.
31. Parker RM, Herzog H. Regional distribution of Y-receptor subtype mRNAs in rat brain. Eur J Neurosci 1999; 11(4): 1431-48.
32. Gutman AR, Yang Y, Ressler KJ, Davis M. The role of neuropeptide Y in the expression and extinction of fearpotentiated startle. J Neurosci 2008; 28(48): 12682-90.
33. Heilig M. Antisense inhibition of neuropeptide Y (NPY)-Y1 receptor expression blocks the anxiolytic-like action of NPY in amygdala and paradoxically increases feeding. Regul Pept 1995; 59(2): 201-5.
34. Kask A, Rago L, Harro J. Alpha-helical CRF(9-41) prevents anxiogenic-like effect of NPY Y1 receptor antagonist BIBP3226 in rats. Neuroreport 1997; 8(16): 3645-7.
35. Nakajima M, Inui A, Asakawa A, et al. Neuropeptide Y produces anxiety via Y2-type receptors. Peptides 1998; 19(2): 359-63.
36. Sajdyk TJ, Fitz SD, Shekhar A. The role of neuropeptide Y in the amygdala on corticotropin-releasing factor receptormediated behavioral stress responses in the rat. Stress 2006; 9(1): 21-8.
37. Giesbrecht CJ, Mackay JP, Silveira HB, Urban JH, Colmers WF. Countervailing modulation of Ih by neuropeptide Y and corticotrophin-releasing factor in basolateral amygdala as a possible mechanism for their effects on stress-related behaviors. J Neurosci 2010; 30(50): 16970-82.
38. Kash TL, Winder DG. Neuropeptide Y and corticotropinreleasing factor bi-directionally modulate inhibitory synaptic transmission in the bed nucleus of the stria terminalis. Neuropharmacology 2006; 51(5): 1013-22.
39. Hammack SE, Mania I, Rainnie DG. Differential expression of intrinsic membrane currents in defined cell types of the anterolateral bed nucleus of the stria terminalis. J Neurophysiol 2007; 98(2): 638-56.
40. Dumont EC, Williams JT. Noradrenaline triggers GABAA inhibition of bed nucleus of the stria terminalis neurons projecting to the ventral tegmental area. J Neurosci 2004; 24(38): 8198-204.
41. Kudo T, Uchigashima M, Miyazaki T, et al. Three types of neurochemical projection from the bed nucleus of the stria terminalis to the ventral tegmental area in adult mice. J Neurosci 2012; 32(50): 18035-46.
42. Tan KR, Yvon C, Turiault M, et al. GABA neurons of the VTA drive conditioned place aversion. Neuron 2012; 73(6): 1173-83.
43. Jennings JH, Sparta DR, Stamatakis AM, et al. Distinct extended amygdala circuits for divergent motivational states. Nature 2013; 496(7444): 224-8.
44. Ozaki S, Narita M, Iino M, Sugita J, Matsumura Y, Suzuki T. Suppression of the morphine-induced rewarding effect in the rat with neuropathic pain: implication of the reduction in muopioid receptor functions in the ventral tegmental area. J Neurochem 2002; 82(5): 1192-8.
45. Ikegami D, Yamashita A, Narita M. Understanding of the psychiatry in palliative care: Dysfunction of the rewarding system under the pain state associated with exacerbating pain. Jpn J Neuropsychopharmacol 2013; 33: 199-204.
46. King T, Vera-Portocarrero L, Gutierrez T, et al. Unmasking the tonic-aversive state in neuropathic pain. Nat Neurosci 2009; 12(11): 1364-6.
47. Navratilova E, Xie JY, Okun A, et al. Pain relief produces negative reinforcement through activation of mesolimbic reward-valuation circuitry. Proc Natl Acad Sci U S A 2012; 109(50): 20709-13.
48. Goesling J, Clauw DJ, Hassett AL. Pain and depression: an integrative review of neurobiological and psychological factors. Curr Psychiatry Rep 2013; 15(12): 421.
49. Nestler EJ, Carlezon WA, Jr. The mesolimbic dopamine reward circuit in depression. Biol Psychiatry 2006; 59(12): 1151-9.
50. Stoy M, Schlagenhauf F, Sterzer P, et al. Hyporeactivity of ventral striatum towards incentive stimuli in unmedicated depressed patients normalizes after treatment with escitalopram. J Psychopharmacol 2012; 26(5): 677-88